Literature DB >> 12874410

Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy.

Daniel Tarsy1, Diana Apetauerova, Patricia Ryan, Thorkild Norregaard.   

Abstract

A 59-year-old woman with levodopa-responsive parkinsonism complicated by motor fluctuations and generalized levodopa dyskinesia underwent bilateral subthalamic deep brain stimulation (STN DBS) 7 years after symptom onset. DBS improved levodopa-responsive upper extremity bradykinesia but aggravated speech, swallowing, and gait. Motor fluctuations were not improved and levodopa dose remained unchanged. Pulse generators were turned off. Clinical features and brain MRI in this case were indicative of multiple system atrophy (MSA). STN DBS is not recommended for patients with MSA.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12874410     DOI： 10.1212/01.wnl.0000073986.74883.36

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  9 in total

1.  Deep brain stimulation response in pathologically confirmed cases of multiple system atrophy.

Authors:  Michael Ullman; Vinata Vedam-Mai; Andrew S Resnick; Anthony T Yachnis; Nikolaus R McFarland; Stacy Merritt; Pamela Zeilman; Kelly D Foote; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2011-10-07       Impact factor: 4.891

2.  Multiple system atrophy: current and future approaches to management.

Authors:  Olivier Flabeau; Wassilios G Meissner; François Tison
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

Review 3.  Neuroimaging and therapeutics in movement disorders.

Authors:  Thomas Eckert; David Eidelberg
Journal:  NeuroRx       Date:  2005-04

4.  Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy.

Authors:  Ron Levy; Andres M Lozano; Anthony E Lang; Jonathan O Dostrovsky
Journal:  Exp Brain Res       Date:  2010-06-10       Impact factor: 1.972

5.  Computational modeling of pedunculopontine nucleus deep brain stimulation.

Authors:  Laura M Zitella; Kevin Mohsenian; Mrinal Pahwa; Cory Gloeckner; Matthew D Johnson
Journal:  J Neural Eng       Date:  2013-05-31       Impact factor: 5.379

Review 6.  Current Concepts in the Treatment of Multiple System Atrophy.

Authors:  Santiago Perez-Lloret; Olivier Flabeau; Pierre-Olivier Fernagut; Anne Pavy-Le Traon; María Verónica Rey; Alexandra Foubert-Samier; Francois Tison; Olivier Rascol; Wassilios G Meissner
Journal:  Mov Disord Clin Pract       Date:  2015-02-02

7.  Deep brain stimulation in multiple system atrophy mimicking idiopathic Parkinson's disease.

Authors:  Navamayooran Thavanesan; Martin Gillies; Michael Farrell; Alex L Green; Tipu Aziz
Journal:  Case Rep Neurol       Date:  2014-10-23

8.  Case report: Combined therapy of bilateral subthalamic nucleus deep brain stimulation and spinal cord stimulation significantly improves motor function in a patient with multiple system atrophy with predominant parkinsonism.

Authors:  Jiping Li; Shanshan Mei; Xiaohua Zhang; Yunpeng Wang; Xiaofei Jia; Jinlong Liu; Erhe Xu; Wei Mao; Yuqing Zhang
Journal:  Front Neurosci       Date:  2022-08-01       Impact factor: 5.152

9.  The natural history of multiple system atrophy: a prospective European cohort study.

Authors:  Gregor K Wenning; Felix Geser; Florian Krismer; Klaus Seppi; Susanne Duerr; Sylvia Boesch; Martin Köllensperger; Georg Goebel; Karl P Pfeiffer; Paolo Barone; Maria Teresa Pellecchia; Niall P Quinn; Vasiliki Koukouni; Clare J Fowler; Anette Schrag; Christopher J Mathias; Nir Giladi; Tanya Gurevich; Erik Dupont; Karen Ostergaard; Christer F Nilsson; Håkan Widner; Wolfgang Oertel; Karla Maria Eggert; Alberto Albanese; Francesca del Sorbo; Eduardo Tolosa; Adriana Cardozo; Günther Deuschl; Helge Hellriegel; Thomas Klockgether; Richard Dodel; Cristina Sampaio; Miguel Coelho; Ruth Djaldetti; Eldad Melamed; Thomas Gasser; Christoph Kamm; Giuseppe Meco; Carlo Colosimo; Olivier Rascol; Wassilios G Meissner; François Tison; Werner Poewe
Journal:  Lancet Neurol       Date:  2013-02-05       Impact factor: 44.182
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.